Home/Filings/4/0001127602-22-002431
4//SEC Filing

Roberts Jonathan C 4

Accession 0001127602-22-002431

CIK 0000064803other

Filed

Jan 27, 7:00 PM ET

Accepted

Jan 28, 4:58 PM ET

Size

11.6 KB

Accession

0001127602-22-002431

Insider Transaction Report

Form 4
Period: 2022-01-27
Transactions
  • Exercise/Conversion

    Common Stock

    2022-01-27$102.26/sh+68,482$7,002,969175,596.717 total
  • Exercise/Conversion

    Stock Option

    2022-01-2768,4820 total
    Exercise: $102.26From: 2016-04-01Exp: 2022-04-01Common Stock (68,482 underlying)
  • Sale

    Common Stock

    2022-01-27$107.50/sh68,482$7,361,815107,114.717 total
Holdings
  • Common Stock

    (indirect: By GRAT)
    34,707
  • ESOP Common Stock

    (indirect: By ESOP)
    6,045
  • Phantom Stock Credits

    Exercise: $1.00Common Stock (1,422.671 underlying)
    1,422.671
  • Common Stock (restricted)

    12,812
Footnotes (3)
  • [F1]All sales were effected pursuant to a Rule 10b5-1 plan.
  • [F2]Option became exercisable in four equal annual installments, commencing 4/1/2016.
  • [F3]Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.

Issuer

CVS HEALTH Corp

CIK 0000064803

Entity typeother

Related Parties

1
  • filerCIK 0001410515

Filing Metadata

Form type
4
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 4:58 PM ET
Size
11.6 KB